This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Debinski, W. Articles by Gibo, D. M. Search for Related Content PubMed PubMed Citation Articles by Debinski, W. Articles by Gibo, D. M.

---

Signaling and Regulation

Fos-Related Antigen 1 Modulates Malignant Features of Glioma Cells

Brain Tumor Center of Excellence, Comprehensive Cancer Center, Departments of Neurosurgery, Radiation Oncology, and Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina

Requests for reprints: Waldemar Debinski, Brain Tumor Center of Excellence, Comprehensive Cancer Center, Departments of Neurosurgery, Radiation Oncology, and Cancer Biology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157. Phone: 336-716-9712; Fax: 336-713-7639. E-mail: debinski{at}wfubmc.edu

Malignant gliomas, and high-grade gliomas (HGG) in particular, are nonmetastasizing but locally infiltrating, hypervascularized brain tumors of poor prognosis. We found previously that a c-fos-inducible vascular endothelial growth factor D is ubiquitously up-regulated in HGG grade IV, glioblastoma multiforme, and that glioblastoma multiforme overexpress Fos-related antigen 1 (Fra-1) rather than the c-Fos. We have thus become interested in the role Fra-1 may play in malignant glioma progression/maintenance, because Fra-1 has the capacity to modulate transcription of a variety of target genes. In this work, we have analyzed the biological effects of ectopic Fra-1 expression or Fra-1 knockdown in malignant glioma cells. Ectopic Fra-1 induced prominent phenotypic changes in all three malignant glioma cell lines examined: H4, U-87 MG, and A-172 MG. These changes were reflected in cells becoming more elongated with larger number of cellular processes. Furthermore, Fra-1 transgene caused H4 cells, which do not form tumor xenografts, to regain tumorigenic capacity. The genotype of these cells changed too, because 50 of 1,056 genes examined became either up-regulated or down-regulated. Conversely, Fra-1 knockdown altered prominently the morphology, anchorage-independent growth, tumorigenic potential, and Fra-1 effector expression, such as vascular endothelial growth factor D, in HGG cells. For example, cells transfected with antisense fra-1 showed shorter cellular processes than the control cells that did not grow in agar, and their tumorigenic potential was significantly diminished. Thus, Fra-1 may likely play an important role in the maintenance/progression of malignant gliomas and potentially represents a new target for therapeutic interventions.

This article has been cited by other articles:

				M. E. Ramos-Nino, S. R. Blumen, T. Sabo-Attwood, H. Pass, M. Carbone, J. R. Testa, D. A. Altomare, and B. T. Mossman HGF Mediates Cell Proliferation of Human Mesothelioma Cells through a PI3K/MEK5/Fra-1 Pathway Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 209 - 217. [Abstract] [Full Text] [PDF]

				J. Wykosky, D. M. Gibo, C. Stanton, and W. Debinski Interleukin-13 Receptor {alpha}2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy Clin. Cancer Res., January 1, 2008; 14(1): 199 - 208. [Abstract] [Full Text] [PDF]

				J. Wykosky, D. M. Gibo, and W. Debinski A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor expressing tumor cells Mol. Cancer Ther., December 1, 2007; 6(12): 3208 - 3218. [Abstract] [Full Text] [PDF]

				P. Adiseshaiah, D. J. Lindner, D. V. Kalvakolanu, and S. P. Reddy FRA-1 Proto-Oncogene Induces Lung Epithelial Cell Invasion and Anchorage-Independent Growth In vitro, but Is Insufficient to Promote Tumor Growth In vivo Cancer Res., July 1, 2007; 67(13): 6204 - 6211. [Abstract] [Full Text] [PDF]

				K. Kakumoto, K. Sasai, T. Sukezane, C. Oneyama, S. Ishimaru, K. Shibutani, H. Mizushima, E. Mekada, H. Hanafusa, and T. Akagi FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts PNAS, April 4, 2006; 103(14): 5490 - 5495. [Abstract] [Full Text] [PDF]

				J. Wykosky, D. M. Gibo, C. Stanton, and W. Debinski EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme Mol. Cancer Res., October 1, 2005; 3(10): 541 - 551. [Abstract] [Full Text] [PDF]

				W. Debinski Personalized, Multivalent, and More Affordable: The Globalization of Vaccines Clin. Cancer Res., August 15, 2005; 11(16): 5663 - 5664. [Full Text] [PDF]